对瘤组合治疗方案的价值赋值:超越框架,平衡创新,获取和负担能力
Jennifer G Gaultney1, Daniel Ollendorf2, Medha Sasane3
1IQVIA, London, United Kingdom.
Frontiers in pharmacology
|July 17, 2025
概括
癌症组合疗法的有限补偿源于复杂的价值评估. 拟议的价值归因框架 (VAFs) 提供了定量解决方案,但需要进一步开发以实现实际应用.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 制药政策 制药政策
背景情况:
- 组合疗法在癌症治疗中至关重要,但由于复杂的价值评估和定价,它们面临偿还挑战.
- 现有的价值评估框架缺乏评估组合疗法的具体方法,特别是关于组件之间的价值归因.
- 在全球范围内,对组合疗法的准入有所不同,许多国家都关注价格和可负担性,而不是特定的价值归因策略.
研究的目的:
- 解决联合癌症治疗中价值赋值的挑战.
- 总结当前市场对组合疗法补偿的方法.
- 提出和讨论两个价值归因框架 (VAF) 以及它们的实际应用.
主要方法:
- 复杂疗法补偿当前市场方法的审查.
- 开发和介绍两个新的价值归因框架 (VAFs).
- 对拟议的VAF的局限性和数据要求进行分析.
主要成果:
- 当前的市场策略往往绕过价值归因,专注于定价和可负担性.
- 两个拟议的VAF提供了定量方法来评估组合疗法中单个组件的价值.
- 现有的VAF面临的局限性包括数据要求,不确定性和在不同市场原型中适用性.
结论:
- 价值归因是确保组合疗法的报销的一个关键但复杂的方面.
- 拟议的VAF为谈判提供了潜在的定量基础,但需要进一步细化和验证.
- 成功实施需要解决数据缺口,多利益相关者合作,以及超越公正价值归因的定制国家框架.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.1K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.1K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
